Igen Biolab Group
  • Home
  • About Us
  • Technology
  • Pipeline
  • Press
    • News
    • Press Releases
    • Events
    • Publications
  • Contact
  • English
    • Español
Select Page
Prevotella diversity, niches and interactions with the human host

Prevotella diversity, niches and interactions with the human host

by Igen BioLab Group | Jun 3, 2021 | News, Publications

The genus Prevotella includes more than 50 characterized species that occur in varied natural habitats, although most Prevotella spp. are associated with humans. In the human microbiome, Prevotella spp. are highly abundant in various body sites, where they are key...
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment

Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment

by Igen BioLab Group | May 27, 2021 | News, Publications

The prognosis of early breast cancer (BC) relies on cell autonomous and immune parameters. The impact of the intestinal microbiome on clinical outcome has not yet been evaluated. Shotgun metagenomics was used to determine the composition of the fecal microbiota in 121...
Diet, gut microbes affect cancer treatment outcomes

Diet, gut microbes affect cancer treatment outcomes

by Igen BioLab Group | Jun 23, 2020 | News, Publications

What we eat can affect the outcome of chemotherapy – and likely many other medical treatments – because of ripple effects that begin in our gut, new research suggests. University of Virginia scientists found that diet can cause microbes in the gut to...

Recent Posts

  • Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
  • A synthetic consortium of 100 gut commensals modulates the composition and function in a colon model of the microbiome of elderly subjects
  • ‘Multi-kingdom dialogue’ between internal, external microbiota
  • Gut microbiota-derived short-chain fatty acids promote prostate cancer growth via IGF-1 signaling
  • Diet alters entero-mammary signaling to regulate the breast microbiome and tumorigenesis
  • Aviso legal
  • Política de Privacidad
  • Política de cookies
  • Facebook
  • Twitter
  • Google
  • Instagram
  • RSS
Design by loComunicas
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT